- Jiménez, Josefina
- Villanova, O.
- Maisanaba, Sara
- Llana-Ruíz-Cabello, María
- Valero, Eva
- Repetto, Guillermo
- Oriol, Luis
Resumen del póster presentado a la XXXVIII Reunión Bienal de la Real Sociedad Española de Química, celebrada en el Palacio de Congresos de Granada, del 27 de junio al 30 de junio de 2022., One of the most important use of phosphazenes today involves its biomedical applications. Notably, biocompatibility and biodegradability can be regulated by the introduction of specific side groups, R, both in cyclophosphazenes derivatives (CPZs) and their analogue polymers, polyphosphazenes (PPZs), [NPR2]n. Nowadays, the use of PPZs in drug-delivery applications has become a significant focus. Macromolecular pro-drugs are known to exhibit improved body distribution, prolonged blood circulation and passive or active tumor targeting. CPZs can be used as core of dendrimers giving rise to a wide variety of branched molecules, and can also be used as scaffolds for the design and construction of a variety of ligands to conjugate metallodrugs. Several authors have prepared and studied the antitumoral properties of cyclo- or polyphosphazene-platinum(II) conjugates, and we have recently reported metallo-cyclophosphazenes containing gold or silver, which have outstanding antimicrobial or antitumoral properties. Herein, we present new dendrimers based on a cyclotriphosphazene as a central core with dendrons derived from 2,2-di(hydroxymethyl)propionic acid, bis(MPA), which have been further functionalized at their terminal positions with pyridine donor units to obtain gold or silver metallodendrimers, G0-(pyM)6, G1-(pyM)12 and G2-(pyM)24 (See Chart 1 for Generation 2 metallodendrimers having 24 pyridine peripheral groups, G2-(pyM)24: Structure of metallodendrimers G2-(pyM)24). Studies of their anti-cancer activity in the human breast adenocarcinoma (MCF7) and human hepatocellular carcinoma (HepG2) cell lines were carried out. IC50 values revealed an excellent antitumor activity for these metal complexes, compared with their precursors, cisplatin and auranofin. Structure-activity relationships are discussed in order to determine the influence of ancillary ligands and the number and type of metal atoms (silver or gold)., MINECO (MAT2017‐84838‐P), Gobierno de Aragón-FSE and FEDER, Junta de Andalucía (VPPI-UPO) (2019-PPI1901, 2021-PPI2101) and FEDER-UPO-1380882., Peer reviewed